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Objective. To determine whether estimation of left ventricular (LV) ejection fraction (EF) by means of multiple gated
acquisition (MUGA) scanning could reliably stratify cardiac risk prior to elective major vascular surgery.
Methods. A review of the English-language literature.
Results and Conclusions. Twenty-two studies enrolling a total of 3096 patients were identified from 1984 to date.
Selection bias, blinding of the results, different cut-off limits, and several retrospective studies were some of the problems
preventing a comprehensive analysis. The resting LVEF was not found to be a consistent predictor of perioperative ischaemic
cardiac events. In the perioperative phase, poor LV function was, mainly, predictive of congestive heart failure, and, in the
long-term, of cardiac outcome. The presence of myocardial wall motion abnormalities was also associated with both a higher
chance of postoperative cardiac complications and a worse long-term cardiac outcome. Although measurements of LV
function seem to play a key role in defining a patient’s long-term prognosis, the value of routinely measuring LVEF
preoperatively is limited and, therefore, MUGA scanning cannot be recommended as a general screening test. Despite this, it
has been widely used for cardiac risk assessment in vascular surgery, and only recently its popularity has started declining.
Other tests, such as stress-echocardiography and myocardial perfusion imaging, used selectively in moderate-risk patients
can refine prediction of cardiac risk. In the future, gated stress myocardial perfusion scintigraphy, perhaps combined with
ANP/BNP plasma level determination, may become a first choice test in preoperative cardiac risk assessment.
Key Words: Preoperative cardiac assessment; Cardiac risk prediction; Vascular surgery; Radionuclide ventriculography;
Multiple gated acquisition scanning; Radioisotope left ventricular ejection fraction.
Introduction
Coronary artery disease (CAD) is the leading cause of
morbidity and mortality after major vascular surgery.
Such patients consume a relatively large proportion of
health service resources and their preoperative assess-
ment and perioperative care are common concerns for
surgeons, anaesthetists, cardiologists, and physicians.
Cardiac risk stratification is important because identi-
fication of individuals at increased risk may allow
important alterations in perioperative management. In
the preparation of a patient for elective major vascular
surgery, a variety of testing modes are available. These
range from simple clinical evaluations, through a
variety of imaging, stress testing procedures, and
electrocardiographic (ECG) analysis, to coronary
angiography. Numerous studies have attempted to
identify strategies for stratifying candidates for major
vascular surgery, but, so far, none has gained universal
acceptance.1 – 3 Although nuclear cardiology offers
sophisticated options of cardiac assessment, debate
continues regarding the value of nuclear cardiac
imaging prior to vascular surgery. Multiple gated
acquisition (MUGA) scanning, in particular, has been
used to assess cardiac function and stratify periopera-
tive cardiac risk for more than two decades, its role,
however, remains controversial. The aim of this study
is to review the evidence concerning the role and the
usefulness of MUGA scanning to predict cardiac risk
prior to elective major vascular surgery.
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Methods
An English-language literature review was under-
taken through to November 2003 to define the role of
preoperative cardiac assessment using resting MUGA
scanning prior to major elective vascular surgery. An
electronic PubMed and Medline search was per-
formed using the terms: ‘noncardiac surgery’ or
‘vascular surgery’, combined with ‘coronary artery
disease’, ‘cardiac assessment’, ‘cardiac risk prediction’,
‘cardiac risk stratification’, ‘perioperative care’, ‘post-
operative complications’, ‘multiple gated acquisition
scan’, ‘radionuclide ventriculography’, ‘radionuclide
angiocardiography’, ‘radionuclide cardioangiogra-
phy’, ‘radioisotope left ventricular ejection fraction’,
‘gated radionuclide angiography’, ‘gated heart blood
pool scan’, ‘gated blood pool imaging’, and ‘gated pool
ejection fraction’. References from the relevant articles
were also searched. Studies comparing MUGA scan-
ning to other functional cardiac tests, mainly review
and meta-analysis articles were also identified. Selec-
tion of studies and data abstracting were performed
independently by two of us (CDK, MSB) and
discrepancies were resolved by consensus.
Results
Left ventricular ejection fraction (LVEF) is the single
most important prognostic parameter in patients with
CAD and many clinical management decisions are
based on this.4,5 Two-dimensional echocardiography,
radionuclide ventriculography techniques, and con-
trast cineangiography are all equally acceptable
methods of estimating LVEF. Echocardiography is
noninvasive and usually adequate for the assessment
of left ventricular (LV) performance, but has the
disadvantage of being a much less accurate and
more operator-dependent method. MUGA scanning
is used less often these days because of the increase in
echocardiography but remains the investigation of
choice for the noninvasive quantification of LV
function. When compared to echocardiography, radio-
isotope LVEF is both accurate and highly reproduci-
ble.6 – 8 Therefore, when a precisely reproducible
measurement is required for patient management
decisions, MUGA scanning is the method of choice.
This is recognised and radioisotope LVEF has been
used extensively as a means of preoperative cardiac
risk assessment. A study comparing radioisotope with
echocardiographic LVEF found the correlation of
LVEF determined by both methods to be good
(Pearson correlation coefficient r ¼ 0:81; SEE ¼ 3.5)
and so was intra- and inter-observer reproducibility.7
Both the latter were better for radioisotope LVEF than
echocardiographic LVEF. Clinically relevant differ-
ences did not occur on repeat processing of MUGA
scanning, whereas potentially clinically relevant
differences occurred in 8–26% of studies on repeat
analysis of echocardiography.
A total of 24 studies looking at whether a resting
radioisotope LVEF could predict adverse cardiac
events in the postoperative period were identified in
the English-language literature.9 – 32 One repeat publi-
cation from the same institution with overlapping
study periods,31 and a further one, using the first-pass
rather than the equilibrium ventriculography,32 were
excluded. This left 22 studies for analysis, with a total
of 3096 patients from 1984 to date.9 – 30
There was significant heterogeneity between
studies with regards to study design, patient selection,
blinding of tests results, positivity criteria for the
MUGA test, and definition of cardiac end points. A
summary of the clinical characteristics of each study is
presented in Table 1. These differences and the
inconsistency in the reporting of the results presented
several problems preventing a true meta-analysis of
the subject. MUGA scanning may have been per-
formed in consecutive patients presenting for surgery
or in selected patients chosen according to clinical
criteria. The predictive value of the scan is likely to be
higher when selected patients are tested. Selection bias
occurs because those deemed to be at higher risk on
clinical grounds are more likely to get the test.33 The
predictive value of MUGA scanning is likely to be
lower in unblinded studies, because patients with
positive test results may undergo conservative oper-
ations, receive haemodynamic monitoring and stay
longer in the intensive care unit.24,33 Such care may
decrease the rate of adverse cardiac outcome after
surgery. Studies in which patients are recruited
consecutively and physicians are blinded to the results
are likely to provide a relatively unbiased predictive
accuracy.33 Additionally, different studies employed
different statistical methods in analysing the results.
Some examined LVEF as a continuous variable,
whereas others as a dichotomous one. Some used
univariate analysis, whereas others employed logistic
regression. Another problem making studies noncom-
parable was the differences in the study populations as
reflected by the wide variety of ‘higher’ risk non-
cardiac surgical operations included. Finally, another
limitation is that the retrieved articles cover a time
span of 20 years. No doubt, the quality of gamma
cameras, radioisotopes and computer software has
evolved and improved with time. Therefore, one
should take into account the potential differences in
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Table 1. Studies (in chronological order) which examined the prognostic value of radioisotope LVEF in predicting cardiac morbidity and mortality after different types of surgical
procedures (Refs. 9–30)
Study (Ref.
no.)
No. of
patients
Type of study Technique Positivity
criteria
Cardiac
events (total
pts)
Definition of cardiac endpoints Association between
LVEF and cardiac
events
Type of surgery
Commin
19849
34 Prospective LAO and anterior plane ,50% 0(8) All cardiac events No Aortic
Unblinded 12 Images/projection, 500
heartbeats
$50% 0(26)
Pasternack
198410
50 Retrospective 12 min #35% 4(5) MI Yes AAA repair
Unblinded 16-Interval gate 36–55% 4(20)
$56% 0(25)
Pasternack
198511
100 Retrospective 12 min #35% 6(8) MI Yes Lower limb
revascularisation
Unblinded 16-Interval gate 36–55% 8(42)
$56% 0(50)
Mosley
198512
41 Prospective LAO plane ,30% 3(4) Cardiac death Yes Aortic
Unblinded 16-Frame cycle (4–5 min) .30% 1(37)
Kazmers
198813
73 NA LAO, anterior and left lateral
plane
#35% 3(7) MI, CHF and new ventricular
arrhythmia
Yes Carotid
.35% 7(75)
Lazor
198814
196 Retrospective NA #35% 8(41) Cardiac death Yes Cardiac, vascular
and general
surgical
36–54% 3(56)
$55% 2(91)
Kazmers
198815
60 NA LAO, anterior and left lateral
plane
#35% 1(10) MI No AAA repair
.35% 3(50)
Franco
198916
85 Retrospective LAO, steep LAO and anterior
plane
#35% 3(15) MI No Lower limb
revascularisation
1 mg stannous pyrophospate þ 20
mCi of Tc99m pertechnetate
(20 min) 28-interval gate, 4 million
counts
36–55% 3(20)
$56% 9(50)
McCann
198917
104 Retrospective NA #35% 1(19) Cardiac death No AAA repair
Unblinded .35% 2(85)
Fletcher
198918
72 Prospective LAO, modified in vivo method,
stannous pyrophosphat e injected
iv; 900 MBq Tc99m, 24 frames on a
64 £ 64 matrix, 4 million counts
#35% 3(10) All cause mortality Yes AAA repair
Unblinded .35% 0(62)
#45% 5(16) Cardiac failure
.45% 3(56)
E
je
c
tio
n
F
ra
c
tio
n
P
rio
r
to
V
a
s
c
u
la
r
S
u
rg
e
ry
2
2
9
E
u
r
J
V
asc
E
n
d
o
v
asc
S
u
rg
V
o
l
27,
M
arch
2004
Table 1 Continued
Study (Ref.
no.)
No. of
patients
Type of study Technique Positivity
criteria
Cardiac
events (total
pts)
Definition of cardiac endpoints Association between
LVEF and cardiac
events
Type of surgery
Pedersen
199019
95 Prospective ,50% 21(36) Cardiopulmonary complications Yes Noncardiac
Blinded NA $50% 7(59)
McPhail
199020
85 Prospective LAO and LPO views, in vivo
method with 25 mCi of Tc99m
,50% 9(17) Cardiac complications and death No Aortic
$50% 24(68)
Matley
199121
183 Prospective Anterior, LAO and left lateral
plane
#50% 11(38) Major cardiac events (MI, CHF
and malignant ventricular
arrhythmia)
Yes,* WMA Aortic
Unblinded .50% 10(143)
#45% 8(24)
.45% 13(157)
$40% 6(17)
.40% 15(164)
#35% 5(8)
.35% 16(173)
Bunt
199222
630 Prospective NA ,35% 5(57) MI No† Vascular
Unblinded $35% 0(571)
Louridas
199223
131 Retrospective NA #35% 2(11) Cardiac death No Vascular
Unblinded 36–54% 2(38)
$55% 2(82)
Baron‡
199424
457 Prospective In vitro labelling of red cells ,50% 22(75) Prolonged myocardial ischaemia,
MI, CHF and ventricular
arrhythmia
No Aortic
Unblinded 250 cycles (12 frames) $50% 64(382)
Galland
199525
48 Prospective In vivo labelling, 700MBq Tc99m,
400 heartbeats
,35% 4(6) All cardiac events (major and
minor)
No Aortic
Unblinded $35% 13(42)
Schueppert
199626
394 Prospective NA ,35% 1(24) Nonfatal MI No§ Vascular
Unblinded $35% 7(339)
Cohen‡
199827
104 Prospective NA NA NA All-cause mortality and
complications
No AAA repair
Unblinded
Heiba‡
199928
101 Unblinded LAO, anterior and left lateral
plane, 25–30 mCi Tc99m, 4–6
millions counts, 64 £ 64 word
matrix
,50% 12(42) Major cardiac events (MI,
pulmonary oedema and cardiac
death)
No{ Vascular
$50% 5(59)
Mamode‡
200129
297 Prospective 40 and 758 LAO plane, 24 frame
cycle
NA NA Cardiac death, MI, CHF, unstable
angina and serious arrhythmias
No{ Vascular
Unblinded 3 mg pyrophosphate 600 MBq
Tc99m
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the techniques used in each study when interpreting
the results.
Ejection fraction and postoperative ischaemic cardiac events
Studies looking at whether a resting radioisotope
LVEF could predict adverse cardiac events in the
postoperative period have produced conflicting
results. Traditionally, patients with LV dysfunction,
reflected by a decrease in LVEF, have been considered
at high risk for postoperative cardiac complications.
Indeed, eight studies, reporting on 810 patients, have
shown that preoperative resting LVEF could predict
postoperative myocardial events.10 – 14,18,19,21 All these
earlier studies employed univariate analysis and none
have carried out adjusted analyses to account for
correlation between risk factors. In contrast, the
remaining fourteen studies failed to show a statistical
association between preoperative resting LVEF and
ischaemic cardiac complications. Only five of these
studies have used logistic regression to test for
associations between variables.24,27 – 30
The above data suggest that resting LVEF is not a
consistent predictor of postoperative ischaemic cardiac
complications. This is not surprising since the resting
LVEF gives only a simple estimate of the systolic
function of the LV under the existing loading con-
ditions. Not infrequently, the ejection fraction may be
normal in a heart with advanced CAD until the
myocardium is stressed. Such patients may be high-
risk, and as a result, a normal resting LVEF is by no
means reassuring that a patient is at low risk for
cardiac complications in the postoperative period.
Similarly, resting LV function measured by echocar-
diography has not been found to be a consistent
predictor of perioperative ischaemic events.25,34 Some
studies found it useful, others did not.25,34 – 41 In a
recent Vascular Anaesthesia Society audit of 933
patients undergoing nonemergency infrarenal aortic
surgery throughout the British Isles, assessment of
LV function by echocardiography was obtained in
almost half of them.35 The mortality rate in patients
who had echocardiography was no different than
those who did not (8.2% versus 6.5%, adjusted odds
ratio 1.31 (95% confidence interval 0.79 – 2.18),
P ¼ 0:29). Additionally, in the echocardiography
group, there was no significant difference in mortality
rate between patients with good, impaired, and
severely impaired LV function.
Ejection fraction and postoperative cardiac failure
Three studies documented that resting radioisotopeT
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LVEF was predictive of postoperative LV failure.18,21,24
Fletcher et al. found that a LVEF less than 45% was
associated with a higher likelihood of postoperative
LV failure,18 whereas Baron et al. showed similar
associations with a cut-off LVEF of 50%.24 Similarly,
Matley et al. demonstrated a consistent correlation
between LVEF and postoperative cardiac failure/
pulmonary oedema using several different cut-off
points of LVEF (i.e. 50, 45, 40 and 35%).21
Ejection fraction and late cardiac outcome
Preoperative LVEF has also been shown to be
associated with significantly reduced overall long-
term survival after successful vascular surgery.15,42
However, McCann and Wolfe found no such associ-
ation in a group of patients undergoing abdominal
aortic aneurysm repair and they concluded that
patients should not be denied aneurysm resection
solely on the basis of LVEF.17 When considering
patients with severely impaired LV function (LVEF of
35% or less), Kazmers et al. found that patients with an
LVEF of 29% or less formed a subgroup at even greater
survival disadvantage and recommended that surgery
should be performed for only the most compelling
indications.43 These findings are hardly surprising, as
several studies indicate that resting LVEF at the time of
the initial evaluation is highly predictive of sub-
sequent outcome in nonsurgical patients with
CAD.44 – 46 Of particular importance is that the
relationship is not linear. Prognosis changes very little
within the range of LVEFs from 45 to 65%; however,
once LVEF drops below 40%, mortality increases
exponentially.45
Ventricular wall motion abnormalities and postoperative
cardiac complications
In addition to determination of LVEF, MUGA scanning
can also show ventricular wall motion abnormalities
(akinesis, hypokinesis, dyskinesis). These may be
present at rest or with exercise. Only two studies
have addressed the importance of myocardial wall
motion abnormalities in predicting postoperative
cardiac complications.21,30 It appears that patients
with wall abnormalities both with, or without an
abnormal ejection fraction, are more likely to suffer a
postoperative cardiac problem. A further study
demonstrated that ventricular wall motion abnormal-
ities were also associated with reduced overall
survival after successful lower limb bypass surgery.42
The association between wall motion abnormalities
and adverse cardiac events is not unique to MUGA
scanning. Myocardial wall motion abnormalities
detected by resting transthoracic echocardiography
are also predictive of perioperative cardiac compli-
cations.36
MUGA scanning as compared to other functional cardiac
tests
Many would argue that other functional cardiac tests,
such as the myocardial perfusion imaging and stress
echocardiography, are superior to MUGA scanning in
terms of predicting cardiac morbidity or death after
major vascular surgery. Resting MUGA scan differs
from myocardial perfusion imaging studies or stress
echocardiography in that it measures the LVEF and
detects wall motion abnormalities at rest. The latter
studies are more invasive and use pharmacological
stress to test for myocardial ischemia that is mani-
fested as reversible or fixed perfusion defects and wall
motion abnormalities. Considering abdominal aortic
surgery, in particular, it has been suggested that stress
tests are superior, as they may simulate, to a certain
extent, the stress exerted upon the myocardium
during crossclamping and declamping of the aorta.
Dipyridamole-thallium scanning (DTS) is the most
extensively studied noninvasive approach to the
cardiac risk stratification with a reversible perfusion
defect generally found to be the most powerful
covariable associated with perioperative cardiac
events.47 – 49 This has been shown to be highly sensitive
for the detection of coronary stenoses. In addition, a
negative test indicates a low risk for cardiac compli-
cations i.e. has a high negative predictive value.
However, the frequent false-positive results particu-
larly with single photo perfusion scintigraphy, is a
major limitation of this test. Attenuation artefacts such
as breast tissue and the diaphragm can produce
apparent perfusion defects.50 Normal scans signifi-
cantly reduce the likelihood of perioperative cardiac
complications, whereas patients with redistribution
have a higher cardiac risk than those with a persistent
perfusion defect.47 – 49 There is an incremental increase
in the probability of postoperative cardiac events with
increasing size and number of reversible defects.
Quantification of delayed redistribution is more
predictive of cardiac death or myocardial infarction
than simple dichotomous interpretation in positive/
negative results. A recent meta-analysis confirmed
that semiquantitative myocardial perfusion imaging
could provide better estimates of perioperative risk
than nonquantitative scintigraphy.51 Reversible
defects in less than 20% of myocardial segments do
not significantly alter the risk of perioperative cardiac
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complications, whereas greater extents reversibility
increase the risk after noncardiac vascular surgery.
Pooled data from 24 studies on 3354 patients under-
going vascular surgery indicate that DTS has sensi-
tivity for the prediction of adverse perioperative
cardiac events of 83% and a specificity of 49%.50,52
Stress echocardiography with dobutamine (DSE) or
dipyridamole (DiSE) is an alternative stress test for
vascular surgical candidates. Tissue harmonics has
improved the accuracy of endocardial delineation and
it will likely reduce intra- and inter-observer varia-
bility, which is one of the major limitations of the test.50
Patients demonstrating extensive ischaemia under
dobutamine stimulation (.5/16 LV segments
involved), experience 10 times more cardiac events
than patients with limited stress-induced ischaemia
(,4 segments involved).53 According to most meta-
analyses, it offers the best prediction for perioperative
events, with a negative predictive value close to 100%
and a positive predictive value up to 38% among
intermediate- and high-risk patients, even if it does not
add discriminative power in patients with no clinical
markers of CAD.54
There have been few comparisons of the various
imaging techniques used for perioperative risk assess-
ment. Comparing MUGA scanning with DTS, McPhail
et al. found that although the two tests had a similar
specificity, the latter was much more sensitive.20 A
further study from the same institution compared
MUGA scanning, exercise ECG-testing, and DTS for
the prediction of cardiac complications following
vascular surgery. DTS, with the greatest sensitivity
and predictive power, was the optimal initial test for
identifying high-risk patients.55 One meta-analysis of
20 studies looked at DTS, resting LVEF estimation by
MUGA scanning, ischaemia monitoring by ambulat-
ory ECG, and DSE, to determine which test was the
most effective in predicting adverse cardiac outcome
after vascular surgery. The data were not definitive in
determining the optimal test because the confidence
intervals overlapped, but DSE had the highest
predictive value.33 These observations were confirmed
by two recent Dutch studies.52,56 In the first, more than
2000 consecutive patients who underwent DSE, DiSE
or DTS before major vascular surgery were studied.56
Both stress echocardiography tests were equally
effective in stratifying cardiac risk, whereas DTS had
a significantly lower prognostic value. The second
study was a meta-analysis of 58 published reports on
8119 vascular patients evaluating the predictive
performance of six noninvasive tests used for perio-
perative cardiac risk stratification.52 The authors
compared the discriminatory value of ambulatory
ECG, exercise-ECG, MUGA scanning, DSE, DiSE, and
myocardial perfusion scintigraphy using an innova-
tive meta-analytic approach. The accuracy of the tests
was compared and presented using a summary
receiver operating characteristic (ROC) curve, and
the performance of individual test was corrected for
selected patient and study characteristics. The study
demonstrated that, compared to other modalities, DSE
showed a positive trend towards a better diagnostic
performance than the other tests, but this was only
significant in the comparison with myocardial per-
fusion scintigraphy. It was suggested that DSE may be
the favoured test in situations where there is valvular
or LV dysfunction.
Exercise or stress MUGA scanning and cardiac risk
prediction
It is likely that the addition of exercise or pharmaco-
logical stress will improve the predictive value of
preoperative MUGA scanning. In the nonoperative
setting, the finding of a major fall (.5%) in LVEF from
rest to exercise carries with it poor prognosis in
patients with CAD.46,57 – 61 The ejection fraction at
peak exercise, rather than its change with exercise may
provide the most valuable prognostic information.
Compared to coronary angiography, exercise MUGA
scanning data could offer comparable prognostic
information noninvasively.57,59 LV function correlates
well with the total extent of myocardial ischaemic
burden, and has been shown to be a stronger predictor
of prognosis than the coronary anatomy.46,57 This is
because the number of diseased coronary arteries is a
fairly simplistic way of describing the extent of CAD
and does not correlate with measured coronary flow
reserve. Combined with clinical information, exercise
radionuclide variables could predict accurately future
events in patients with stable CAD or recent myocar-
dial infarction, and act as surrogate for the catheter-
isation data.46,57 In addition, the response to exercise
before cardiac surgery is a major predictor of sympto-
matic outcome after coronary artery bypass grafting.62
However, the only study to examine the role of stress
MUGA scanning prior to noncardiac surgery found
that only peak workload, and not indices of left
ventricular function, predicted perioperative cardio-
vascular events.63
Combined myocardial function and perfusion data and
cardiac risk prediction
Few studies have examined the additive values of LV
performance at rest and myocardial perfusion in
predicting perioperative cardiac risk. Use of the
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combination of MUGA scanning and myocardial
perfusion imaging has been shown to improve cardiac
stratification as both abnormal radioisotope LVEF and
extent of ischaemic myocardium have independent
and complementary predictive power for cardiac
events in patients undergoing vascular surgery.28
Similarly, the combination of resting echocardiogra-
phy and dipyridamole-thallium scintigraphy can
improve the identification of patients at risk for
perioperative cardiac complications.37 Today, with
the advent of nuclear cardiology, ECG-gated single
photon emission computed tomography (ECG-gated
SPECT) offers combined assessment of both myocar-
dial perfusion and LV function (including LVEF and
volumes) and emerges as a useful adjunct in the
cardiac assessment of high-risk patients with cardio-
vascular disease.64 Whether this would be the ‘ideal’
screening test prior to major noncardiac surgery
remains to be seen.
Combined clinical and radioisotope data and cardiac risk
prediction
Instead of testing all candidates for major vascular
surgery indiscriminately, many surgeons adopt a
Bayesian approach and use clinical criteria to select
patients for further cardiac testing.65 This has been
shown to refine preoperative risk stratification. A
typical example is the use of Eagle criteria to select
candidates for myocardial perfusion imaging.66 Five
clinical variables were identified: diabetes, age . 70
years, Q-wave on ECG, angina, and history of
ventricular ectopic activity. In patients at intermediate
risk (one or two clinical predictors), thallium redis-
tribution could further optimise the cardiac risk
prediction, whereas in those at high (three or more
risk factors) or low risk (no risk factors), DTS could
offer no additional stratification over clinical infor-
mation alone. Similarly, Venzetto et al. showed that the
addition of the results of DTS to clinical data
significantly increased the ability to predict a perio-
perative cardiac event.67 Recently, Poldermans et al.
used DSE to further stratify patients judged as being
high risk according to similar clinical criteria.68 The
role of resting echocardiography, however, is contro-
versial. Halm et al. found that resting echocardio-
graphic variables added little discriminative
information to the clinical data in patients having
noncardiac surgery.40 It is likely that preoperative
transthoracic echocardiography can provide indepen-
dent information about the risk of postoperative
cardiac complications in selected patients only.
Rohde et al. showed that echocardiographic data
other than resting LVEF, including LV function,
hypertrophy indexes, and Doppler-derived measure-
ments, could provide significant incremental infor-
mation for patients at increased risk for cardiac
complications by clinical criteria, but not in otherwise
low-risk patients.36 To date only two studies have
examined whether the combination of clinical criteria
and MUGA scanning could optimise the prediction of
postoperative cardiac events.25,31 The most recent one
applied the new, modified version of the original
Goldman index, the Revised Cardiac Risk Index in
patients undergoing abdominal aortic surgery.31 The
index included the following six risk factors: high-risk
type of surgery, known history of ischaemic heart
disease, congestive heart failure, previous stroke or
transient ischaemic attack, insulin-dependent dia-
betes, and creatinine level more than 2 mg/dl
(177 mmol/l). MUGA scanning could further stratify
cardiac risk only in those considered by the index to be
at high risk, i.e. those with two or more risk factors.
This meant that preoperative MUGA scanning was
unnecessary in low-risk patients, i.e. in approximately
one-fifth of patients in that series. In contrast, an
earlier study comparing the Detsky modification of the
original Goldman Index with MUGA scan data found
no correlation between the two.25
Combined biochemical and radioisotope data and cardiac
risk prediction
Recently, a number of circulating factors have received
close attention as cardiovascular markers that reflect
LV function and/or predict cardiovascular prognosis
in a spectrum of cardiac disease ranging from severe
heart failure from different causes to asymptomatic
ischaemic LV impairment.69,70 Plasma atrial natriuretic
peptide (ANP) and B-type natriuretic peptide (BNP)
(otherwise known as brain natriuretic peptide), their
precursors N-terminal proAtrial (N-ANP) and N-
terminal pro-Brain natriuretic peptides (N-BNP),
catecholamines, renin, and aldosterone have all been
investigated as potential predictors of cardiac func-
tion.69 – 73 Amongst them, BNP and N-BNP are,
probably, the strongest markers for LV dimensions
and LVEF in patients with systolic LV dysfunc-
tion.70 – 73 High concentrations are very well correlated
to low LVEF values. This is an area of intense research
in cardiology, but as yet, no studies have addressed the
value of these peptides in cardiac risk stratification
prior to vascular surgery. Although work is still
ongoing, simple blood tests, such as plasma N-BNP
and BNP measurements may be used in the future to
screen patients with suspected ventricular dysfunction
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and one of these could reasonably be included in the
routine clinical work-up of vascular surgical candi-
dates to reduce the demand for further cardiac
investigations.
Discussion
The best way to identify patients who are at risk of
perioperative cardiac complications after major vas-
cular surgery and who might benefit from further
cardiac testing, alternative cardiac strategies, or
preliminary myocardial revascularisation has yet to
be defined. A negative preoperative test in a particular
patient, although reassuring for the surgeon and the
anaesthetist, does not mean that cardiac complications
are excluded. Perioperative myocardial infarction is a
complex entity, which can be precipitated by a number
of different pathophysiologic mechanisms, including
increases in myocardial oxygen consumption, pro-
longed sympathetic stimulation and tachycardia,
increased vasomotor tone, hypercoagulability, poten-
tial atheromatous plaque rupture leading to thrombus
formation, hypothermia, and blood loss.54 Currently,
there is no single test that adequately mimics all these
factors. Moreover, the culprit lesion causing myocar-
dial infarction often occurs in a insignificantly ste-
nosed coronary artery.
The value of MUGA scanning for predicting
perioperative cardiac events has been assessed by
many studies.9 – 32 However, the increasing use of
echocardiography and the substantial increase of
myocardial perfusion imaging over the last decade
has led to a fall in the popularity of MUGA scanning.
In 1998, a British Nuclear Cardiology Society survey
showed that radionuclide ventriculography use had
fallen in the UK by 47%.74 Nevertheless, it remains the
method of choice where reproducibility or accuracy is
a critical issue, such as in cancer chemotherapy or
major cardiovascular research studies.75,76 Data on
current practice in the preoperative cardiac risk
stratification of patients having major vascular surgery
show MUGA scan to be the second most popular
preoperative cardiac test amongst surgeons and
anaesthetists in the UK.2,3 Although the utilisation
rate varies considerably, 13–19% of the vascular units
in the UK, and 39% of those to which the investigation
is available, use MUGA scan as the investigation of
choice. In the USA, where a much greater utilisation of
cardiological investigation is taking place, preopera-
tive radioisotope LVEF is estimated in 33% of cases.1
According to the current practice guidelines pub-
lished by the American College of Cardiology/Amer-
ican Heart Association (ACC/AHA) and the
American College of Physicians, routine noninvasive
evaluation of LV function prior to elective major
noncardiac surgery is of limited value.77 – 79 Further-
more, a comprehensive meta-analysis recently showed
that a low LVEF has a relatively poor sensitivity, a high
specificity, and no significantly better predictive
performance than other cardiac tests.52 The authors
suggest that the observed limitations may be
explained by the failure of the test to detect severe
underlying CAD, changes in predictive value over
time and improved anaesthetic and surgical perio-
perative care. Thus, MUGA scanning may not be
suitable for preoperative cardiac risk stratification.
This carries important implications considering that as
much as 80% of the vascular anaesthetists in the UK
employ some form of LVEF measurement (echocardio-
graphic or radioisotope) as the initial cardiac test prior
to vascular surgery.3 The ACC/AHA guidelines have
adopted a stepwise approach in the perioperative
cardiac evaluation. Low and high-risk patients should
be best identified on the basis of clinical markers. In
those with intermediate risk as judged by clinical
evaluation, other tests, such as the stress echocardio-
graphy or myocardial perfusion imaging can further
stratify risk. The proposed algorithms, based on
evidence from cohort studies and expert opinion,
appear to be effective in both stratifying cardiac risk,
and reducing resource use and costs without affecting
outcome.80 – 82 Ideally, these recommendations should
be prospectively validated by randomised clinical
trials, however, no such trials have been published
over the past six years.82
In conclusion, although resting MUGA scanning
seems to be useful in cardiac risk stratification and the
overall risk-versus-benefit assessment of candidates
for major vascular surgery, its role in predicting
accurately perioperative ischaemic cardiac events is
inherently limited. Resting LVEF is a static measure of
cardiac function and unless very low may give little
information about how the heart performs under
stress. A low ejection fraction is mainly predictive of
post-operative cardiac failure and long-term survival.
Routine measurement of radioisotope LVEF prior to
major vascular surgery is, therefore, not necessary,
unless there are specific indications similar to those in
the nonoperative setting, for example patients with
current or poorly controlled congestive heart failure,
and, less so, patients with previous congestive heart
failure or those with dyspnoea of unknown aetiology.
Whatever the overall value of preoperative LVEF,
similar information can be gained by echocardiogra-
phy at less cost and with no radiation risk.
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